Drugs with Multiple Targets Show Promise Against Myotonic Dystrophy Type 1

Date

11/30/15

Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1’s many modes of action. Their retooled compounds interrupt the disease’s pathology in three ways.

Graduate students Long Luu and Lien Nguyen, with U. of I. chemistry professor Steven Zimmerman, developed drug compounds that target three pathways associated with myotonic dystrophy type 1.

“We’ve rationally designed something to target multiple pathways, which is contrary to the traditional thinking in medicinal chemistry, where you have one target, one drug,” said University of Illinois chemistry professor Steven Zimmerman, who led the research with graduate students Lien Nguyen and Long Luu. “People are slowly discovering that drugs that hit multiple targets are actually better.”

The team reports its findings in the Journal of the American Chemical Society.

DM1 (but not Duchennes muscular dystrophy) results from a genetic error that causes expansion of a region of a particular gene, called DMPK. This gene includes a repeated, three-letter sequence of nucleotides, the gene’s chemical building blocks. Normal cells contain as many as 35 of these repeats, but sometimes mutation pushes the number of repeats beyond 50, which can lead to symptoms of the disease. Mutant DMPK genes often continue to expand, amplifying the health problems that can result. In some people, the gene includes as many as 10,000 repeats.

No drugs are available to treat DM1, which afflicts an estimated one in 8,000 people worldwide.

Scientists are gradually learning how the disease impairs cells. When mutant DMPK is converted into RNA in a first step of protein production, the repeated sequences in the RNA cause it to bind to another protein, MBNL, which regulates RNA processing. When bound by the mutant RNA, MBNL cannot function properly, causing a cascade of problems in protein production, Zimmerman said.

“Dozens of other proteins become dysregulated,” he said. “There’s a chloride channel that causes heart arrhythmias. There’s an insulin receptor that, when it’s dysregulated, gives diabetic symptoms.”

In earlier work, Zimmerman and his colleagues developed a compound that stopped the mutant RNA from binding to MBNL. But the disease has other means of creating havoc in cells, researchers have since found. For example, the cell translates the mutant RNA into proteins that also turn out to be toxic. And the mutant RNA interferes with the function of other proteins besides MBNL.

“The disease is like a hydra,” Zimmerman said. “You cut off one of its modes of action and we learn about two more that need to be dealt with.”

Nguyen and Luu tackled this problem by tethering new biologically active appendages to the lab’s original compound, creating multitarget drugs that are small enough to get easily into cells. In tests, they found that the new compounds have three modes of action. One, they stop the process by which the mutant DNA is converted into RNA. Two, they bind to the mutant RNA and prevent it from attaching to the regulatory protein, MBNL. And three, they chop up the mutant RNA, a process that is slow but appears to be effective in in vitro experiments.

The most potent compounds the researchers developed reduce levels of the mutant RNA in cells that replicate the pathology of DM1. The new compounds also reversed two symptoms of the disease in a fruit fly model of DM1.

“The new compounds would need to work effectively in mice and pass preclinical benchmarks before they can be tried in humans,” Zimmerman said. “It is encouraging that a different approach using a DNA analog is already in clinical trials in human patients.”

The advantage of the new agents under development in Zimmerman’s lab is their small size, he said.

“Small molecules are much easier to make than larger compounds, they are easier to get into cells and their potential for getting into the brain is higher,” he said.

The research team also included Shaohong Peng and H.Y. Edwin Chan of the Chinese University of Hong Kong and U. of I. graduate student Julio Serrano.

The National Institutes of Health and the Muscular Dystrophy Association supported this research.

Excerpted from UIUC News Bureau article, by Diana Yates

Photo by L. Brian Stauffer

Related People

Directory

scheelinAlexander
Scheeline
bjmccallBenjamin
McCall
cmartn10Calgary
Martin
r-gennisRobert
Gennis
j-gerltJohn
Gerlt
sgranickSteve
Granick
mgruebelMartin
Gruebele
hergenroPaul
Hergenrother
huangRaven
Huang
mlkraftMary
Kraft
leckbandDeborah
Leckband
yi-luYi
Lu
martinisSusan
Martinis
snairSatish
Nair
eoldfielEric
Oldfield
rienstraChad
Rienstra
cmsCharles
Schroeder
zanZaida
Luthey-Schulten
sksScott
Silverman
s-sligarStephen
Sligar
zhao5Huimin
Zhao
mselfba2Michelle
Self-Ballard
pbraunPaul
Braun
mdburkeMartin
Burke
jeffchanJefferson
Chan
sdenmarkScott
Denmark
dlottDana
Dlott
foutAlison
Fout
agewirthAndrew
Gewirth
ggirolamGregory
Girolami
shs3Sharon
Hammes-Schiffer
sohirataSo
Hirata
kamihullKami
Hull
jainPrashant
Jain
jkatzeneJohn
Katzenellenbogen
nmakriNancy
Makri
douglasmDouglas
Mitchell
jsmooreJeffrey
Moore
murphycjCatherine
Murphy
r-nuzzoRalph
Nuzzo
dimerPhilip
Phillips
rauchfuzThomas
Rauchfuss
joaquinrJoaquín
Rodríguez-López
jrogersJohn
Rogers
sarlahDavid
Sarlah
kschweizKenneth
Schweizer
jsweedleJonathan
Sweedler
vddonkWilfred
van der Donk
renskeRenske
van der Veen
vuraweisJosh
Vura-Weis
mcwhite7M.
White
sczimmerSteven
Zimmerman
beakPeter
Beak
wklemperWalter
Klemperer
jdmcdonaJ.
McDonald
mvp11Michael
Pak
pogoreloTaras
Pogorelov
mshen233Mei
Shen
dewoonDavid
Woon
wboulangWilliam
Boulanger
rxbRohit
Bhargava
qchen20Qian
Chen
jianjuncJianjun
Cheng
hy66Hong
Yang
andinomaJosé
Andino Martinez
decosteDonald
DeCoste
thhuangTina
Huang
tjhummelThomas
Hummel
dkellDavid
Kell
doctorkMichael
Koerner
marvilleKelly
Marville
crrayChristian
Ray
tlbrownTheodore
Brown
rmcoatesRobert
Coates
thdjrThom
Dunning,
dykstraClifford
Dykstra
j-jonasJiri
Jonas
j-lisyJames
Lisy
shapleyJohn
Shapley
pshapleyPatricia
Shapley
awieckowAndrzej
Wieckowski
zumdahl2Steven
Zumdahl
ksuslickKenneth
Suslick
jlbearJodi
Bear
jcoxJenny
Cox
ealthausEllen
Althaus
staciryStaci
Ryan
sqdSean
Drummond
dmillsDouglas
Mills
sheeleySarah
Sheeley
jsmaddenJoseph
Madden
cknight4Connie
Knight
schulzeHeather
Schulze
slangleySamantha
Langley
ssmurrayStar
Murray
kbaumgarKeena
Finney
adkssnBeatrice
Adkisson
bmylerBeth
Myler
trabari1Katie
Trabaris
kewatsonKaren
Watson
strussTheresa
Struss
metclfKara
Metcalf
ljohnso2Lori
Johnson
jlwJamison
Lowe
jenruslJennifer
Russell
lchenoweLeslie
Chenoweth
jcfJonathan
Freiman
wdedoWolali
Dedo
ebielserElaina
Kutz
spinnerDavid
Spinner
plblumPatricia
Simpson
stevens2Chad
Stevens
lsagekarLori
Sage-Karlson
bertholdDeborah
Berthold
kecarlsoKathryn
Carlson
tlchen4Timothy
Chen
sdesmondSerenity
Desmond
angelaecAngela
Crawford
hsahmed3Hajira
Ahmed
kakinsKenye
Akins
asali3Arzeena
Ali
axelson2Jordan
Axelson
bai11Yugang
Bai
scbakerStephanie
Baker
duffin2Kevin
Duffin
duttadDebapriya
Dutta
pflotschPriscila
Falagan Lotsch
iflemingIan
Fleming
dgrayDanielle
Gray
thennes2Thomas
Hennessey
mhettingMary Jo
Hettinger
holdaNancy
Holda
holler2Jordan
Holler
aibarrAlejandro
Ibarra
kimshSung Hoon
Kim
kocherg2Nikolai
Kocherginsky
philipk2Philip
Kocheril
dlee106David
Lee
legare2Stephanie
Legare
alewandoAgnieszka
Lewandowska
qianliliQianli
Li
bdmccallBirgit
McCall
smccombiStuart
McCombie
jdm5Justin
McGlauchlen
egmooreEdwin
Moore
myerscouKathleen
Myerscough
snalla2Siva
Nalla
oraham2Aaron
Oraham
lah5LeeAnn
Pannebaker
poonawa2Maria
Poonawalla
rrollerR.
Roller
romanovaElena
Romanova
roubakhiStanislav
Rubakhin
vsfVictoria
Shepherd-Fortner
shvedalxAlexander
Shved
asoudaAlexander
Soudakov
ktsween2Kalee
Sweeney
sktarterSamantha
Tarter
aathoma2Andy
Thomas
kwilhelKaren
Wilhelmsen
wilkeyRandy
Wilkey
luxu3Lu
Xu
yuanyao4Yuan
Yao
silongSilong
Zhang
schlembaMary
Schlembach
emccarr2Elise
McCarren
cmercierChristen
Mercier
atimpermAaron
Timperman
niesShuming
Nie
hshanHee-Sun
Han
mmgMutha
Gunasekera